These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 22543000

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Active approach for breast cancer genetic counseling during radiotherapy: long-term psychosocial and medical impact.
    Baars JE, Bleiker EM, van Riel E, Rodenhuis CC, Velthuizen ME, Schlich KJ, Ausems MG.
    Clin Genet; 2014 Jun; 85(6):524-31. PubMed ID: 24372530
    [Abstract] [Full Text] [Related]

  • 4. Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients.
    Schwartz MD, Lerman C, Brogan B, Peshkin BN, Isaacs C, DeMarco T, Halbert CH, Pennanen M, Finch C.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1003-7. PubMed ID: 15824179
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M, Frydman M, Friedman I, Shiri-Sverdlov R, Papa MZ, Goldman B, Friedman E.
    Am J Med Genet; 2002 Aug 01; 111(2):147-51. PubMed ID: 12210341
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A literature review of the psychological impact of genetic testing on breast cancer patients.
    Schlich-Bakker KJ, ten Kroode HF, Ausems MG.
    Patient Educ Couns; 2006 Jul 01; 62(1):13-20. PubMed ID: 16242293
    [Abstract] [Full Text] [Related]

  • 9. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS, Seminsky M, Honeyford J, Doan B, Franssen E, Meschino W, Chart P, Warner E.
    CMAJ; 2001 Apr 03; 164(7):1005-9. PubMed ID: 11314429
    [Abstract] [Full Text] [Related]

  • 10. The twilight zone between health and sickness: a qualitative exploration with asymptomatic BRCA1 and 2 mutation carriers.
    Dagan E, Goldblatt H.
    Women Health; 2009 Jun 03; 49(4):263-79. PubMed ID: 19753503
    [Abstract] [Full Text] [Related]

  • 11. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
    Hutson SP.
    Oncol Nurs Forum; 2003 Jun 03; 30(2):241-6. PubMed ID: 12692658
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2.
    Metcalfe KA, Poll A, Llacuachaqui M, Nanda S, Tulman A, Mian N, Sun P, Narod SA.
    Clin Genet; 2010 Nov 03; 78(5):411-7. PubMed ID: 20653694
    [Abstract] [Full Text] [Related]

  • 14. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.
    Ardern-Jones A, Kenen R, Eeles R.
    Eur J Cancer Care (Engl); 2005 Jul 03; 14(3):272-81. PubMed ID: 15952973
    [Abstract] [Full Text] [Related]

  • 15. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Bröcker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Tibben A.
    Patient Educ Couns; 2007 Jan 03; 65(1):58-68. PubMed ID: 16872788
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC, Northouse L, Pierce P, Milliron KJ, Liu G, Merajver SD.
    Oncol Nurs Forum; 2011 Sep 03; 38(5):572-81. PubMed ID: 21875844
    [Abstract] [Full Text] [Related]

  • 18. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Bröcker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, van Gool AR, Klijn JG, Tibben A.
    Clin Genet; 2007 Jan 03; 71(1):35-42. PubMed ID: 17204044
    [Abstract] [Full Text] [Related]

  • 19. Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret.
    van Dijk S, van Roosmalen MS, Otten W, Stalmeier PF.
    J Clin Oncol; 2008 May 10; 26(14):2358-63. PubMed ID: 18467728
    [Abstract] [Full Text] [Related]

  • 20. Preoperative genetic testing affects surgical decision making in breast cancer patients.
    Lokich E, Stuckey A, Raker C, Wilbur JS, Laprise J, Gass J.
    Gynecol Oncol; 2014 Aug 10; 134(2):326-30. PubMed ID: 24910453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.